Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Filings indexed 3,374 across all filing types
Latest filing 2022-10-28 Governance Information
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
PROPOSED AMENDMENT TO THE ARTICLES OF ASSOCIATION
Governance Information Classification · 95% confidence The document is an announcement from Yankuang Energy Group Company Limited regarding a proposed amendment to the Articles of Association, specifically deleting 'real estate development and operation' from the company's business scope. It is issued by the Board and intended for submission to the general meeting for discussion. The document does not contain financial statements, audit information, or detailed report data. It is a formal announcement about a governance change (amendment to Articles of Association), which fits best under Governance Information (CGR). The document length is 4538 characters, which is not extremely short, but the content is clearly about governance changes, not a full report or announcement of a report publication. Therefore, the appropriate classification is CGR with high confidence.
2022-10-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2022-10-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2022-10-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2022-10-28 English
ANNOUNCEMENT IN RELATION TO THE RESOLUTIONS PASSED AT THE 2022 SECOND EXTRAORDINARY GENERAL MEETING
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement regarding the resolutions passed at the 2022 second extraordinary general meeting (EGM) of Yankuang Energy Group Company Limited. It details the convening of the EGM, attendance, voting results on various resolutions, compliance with relevant laws and regulations, presence of scrutineers and lawyers, and legal opinions confirming the validity of the meeting and voting. The document is not a full report but an official announcement of voting results and meeting resolutions. It does not contain financial statements or detailed financial analysis, nor is it a proxy solicitation or management report. The content fits the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (12,568 characters) supports it being a full announcement rather than a brief notice or a report publication announcement.
2022-10-28 English
VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING OF THE COMPANY BY THE CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR
Director's Dealing Classification · 95% confidence The document is a voluntary announcement regarding an increase in shareholding by the Chief Executive Officer and Executive Director of the company. It details the purchase of shares by Dr. Jianxin Yang and his resulting shareholding percentage. There is no financial data, no report attached or referenced, and no mention of regulatory filings or financial results. The content focuses on insider share transactions by a company director. According to the filing definitions, this fits the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is 4738 characters, which is consistent with an announcement rather than a full report. Therefore, the correct classification is DIRS with high confidence.
2022-10-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.